Health-System Edition (May 2013 Issue)
Two new medications have recently been approved to help patients lose weight: lorcaserin and phentermine and topiramate extended-release.
News (May 2013)
The LINX Reflux Management System, which was approved by the FDA in 2012, has demonstrated impressive results in a study involving 100 participants with long-term acid reflux.
News (May 2013)
The FDA approved the emergency contraceptive to be sold OTC to girls aged 15 and older, and the Justice Department appealed a judge’s order that it be made available OTC to girls of all ages.
Pharmacy Times (Apr 2013 Issue)
Eliquis (apixaban) tablets are approved to reduce the risk of stroke and systemic embolism in adults with nonvalvular atrial fibrillation.
News (Apr 2013)
The FDA will not approve generic forms of OxyContin that lack abuse-resistant features—and OxyContin’s manufacturer will be able to state that the drug has tamper-resistant properties.
Health-System Edition (Mar 2013 Issue)
The development of multidrug-resistant and extensively drug-resistant tuberculosis in recent decades has made treatment challenging.
Pharmacy Times (Mar 2013 Issue)
Fycompa (perapanel) tablets are approved for the treatment of partial-onset seizures in patients 12 years and older.
Pharmacy Times (Feb 2013 Issue)
Clinical studies support the use of these supplements to promote health.
Pharmacy Times (Feb 2013 Issue)
Xeljanz (tofacitnib) tablets are indicated for adults with moderately to severely active rheumatoid arthritis who have failed methotrexate.
News (Jan 2013)
The new vaccine, Flublok, is made using cultured insect cells and can be produced much more rapidly than conventional flu vaccines, which are grown in chicken eggs.
News (Jan 2013)
Flu shots are in short supply as the 2012-2013 season ramps up a month earlier than usual, but there are signs that this year's outbreak may peak early as well.
Pharmacy Times (Dec 2012 Issue)
Help patients choose the right monitor for their needs.
Pharmacy Times (Dec 2012 Issue)
Truvada (emtricitabine/tenofovir disoproxil fumarate) was approved for prophylaxis to reduce the risk of HIV-1 infection in adults.
Pharmacy Times (Nov 2012 Issue)
Linzess (linaclotide) is approved for treatment of adults with irritable bowel syndrome with constipation or chronic idiopathic constipation.
News (Nov 2012)
Proposed legislation would allow the FDA to track the volume and distribution of drugs produced at compounding pharmacies, provide more information to the public about compounded drugs, and institute a waiver system in times of public need.
News (Oct 2012)
An inhaler from Nephron Pharmaceuticals has brought an OTC asthma medication back to retail stores, filling the gap left when Primatene Mist was discontinued in 2011.
News (Oct 2012)
The FDA’s enforcement action against online pharmacies led to the shutdown of more than 18,000 illegal pharmacy websites and the seizure of $10.5 million worth of pharmaceuticals around the world.
News (Sep 2012)
Eli Lilly’s investigational monoclonal antibody failed to reach its primary endpoints, but it was associated with a significant slowing of cognitive decline in patients with mild Alzheimer’s disease.
Pharmacy Times (Sep 2012 Issue)
Fever can be a sign of a serious underlying illness and can be treated with antipyretics or nonpharmacologic measures.